NLRP10 and Alzheimer disease: An AD risk intergenic single-nucleotide polymorphism (SNP) rs878860 has been suggested to reside within an enhancer region that interacts with NLRP10 by targeted chromosome conformation capture analysis [12], and the AD risk variant was found to down-regulate NLRP10 expression [13].